| A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite NK Kisalu, AH Idris, C Weidle, Y Flores-Garcia, BJ Flynn, BK Sack, ... Nature medicine 24 (4), 408-416, 2018 | 282 | 2018 |
| Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies M Bonsignori, EF Kreider, D Fera, RR Meyerhoff, T Bradley, K Wiehe, ... Science translational medicine 9 (381), eaai7514, 2017 | 207 | 2017 |
| HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells RA Alvarez, RE Hamlin, A Monroe, B Moldt, MT Hotta, ... Journal of virology 88 (11), 6031-6046, 2014 | 149 | 2014 |
| HIV vaccine delayed boosting increases Env variable region 2–specific antibody effector functions D Easterhoff, J Pollara, K Luo, B Janus, N Gohain, LTD Williams, MZ Tay, ... JCI insight 5 (2), e131437, 2020 | 25 | 2020 |
| Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies. Sci Transl Med 9: eaai7514 M Bonsignori, EF Kreider, D Fera, RR Meyerhoff, T Bradley, K Wiehe, ... | 22 | 2017 |
| Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite NK Kisalu, AH Idris, C Weidle, Y Flores-Garcia, BJ Flynn, BK Sack, ... Nature medicine 25 (1), 188-189, 2019 | 5 | 2019 |
| Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies. Sci Transl Med 9,(2017) M Bonsignori, EF Kreider, D Fera, RR Meyerhoff, T Bradley, K Wiehe, ... | 5 | |
| 499 Fierer DS, Simon V, Chen BK. 2014. HIV-1 Vpu antagonism of tetherin inhibits 500 antibody-dependent cellular cytotoxic responses by natural killer cells RA Alvarez, RE Hamlin, A Monroe, B Moldt, MT Hotta, ... J Virol 88, 6031-501, 0 | 3 | |
